Payments to Acquire Property, Plant, and Equipment of Eiger BioPharmaceuticals, Inc. from 31 Dec 2012 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Eiger BioPharmaceuticals, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2023.
  • Eiger BioPharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $216,000.
  • Eiger BioPharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $234,000, a 31% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $340,000, a 51% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $225,000, a 13% decline from 2020.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $234,000 -$106,000 -31% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2024 2023 FY
2022 $340,000 +$115,000 +51% 01 Jan 2022 31 Dec 2022 10-K 08 Apr 2024 2023 FY
2021 $225,000 -$33,000 -13% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023 2022 FY
2020 $258,000 -$217,000 -46% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023 2022 FY
2019 $475,000 +$333,000 +235% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
2018 $142,000 +$98,000 +223% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021 2020 FY
2017 $44,000 -$14,000 -24% 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2020 2019 FY
2016 $58,000 +$13,000 +29% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $45,000 +$42,000 +1400% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018 2017 FY
2014 $3,000 +$1,258 +72% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2017 2016 FY
2013 $1,742 -$46,258 -96% 01 Jan 2013 31 Dec 2013 8-K/A 17 Jun 2016
2012 $48,000 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2015 2014 FY

Eiger BioPharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $216,000 +$216,000 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q1 2022 $0 -$16,000 -100% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $16,000 -$7,000 -30% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $23,000 +$22,000 +2200% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $1,000 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2017 $23,000 +$15,000 +188% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q1 2016 $8,000 +$6,000 +300% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q1 2015 $2,000 -$210,000 -99% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q1 2014 $212,000 +$209,000 +6967% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $3,000 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.